SWOG
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 337
- Registration Number
- NCT00985699
S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2009-09-07
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 220
- Registration Number
- NCT00972751
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1600
- Registration Number
- NCT00949013
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3
Terminated
- Conditions
- Recurrent Lung AdenocarcinomaStage IV Squamous Cell Lung CarcinomaStage IV Lung AdenocarcinomaRecurrent Squamous Cell Lung CarcinomaRecurrent Large Cell Lung CarcinomaStage IV Large Cell Lung Carcinoma
- Interventions
- Biological: BevacizumabOther: Laboratory Biomarker AnalysisBiological: Cetuximab
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1333
- Registration Number
- NCT00946712
- Locations
- 🇺🇸
Riverside Methodist Hospital, Columbus, Ohio, United States
🇺🇸Columbus CCOP, Columbus, Ohio, United States
🇺🇸Grant Medical Center, Columbus, Ohio, United States
S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2
Completed
- Conditions
- Leukemia
- Interventions
- First Posted Date
- 2009-07-24
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 35
- Registration Number
- NCT00945815
- Locations
- 🇺🇸
Wayne Hospital, Greenville, Ohio, United States
🇺🇸Glacier Oncology, PLLC, Kalispell, Montana, United States
🇺🇸Charles F. Kettering Memorial Hospital, Kettering, Ohio, United States
S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment
Phase 2
Withdrawn
- Conditions
- Leukemia
- First Posted Date
- 2009-07-15
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00939328
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1
Withdrawn
- Conditions
- Breast CancerHead and Neck CancerProstate CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Genetic: proteomic profilingOther: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2017-04-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00937417
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2009-07-07
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 142
- Registration Number
- NCT00933127
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: endocrine therapyRadiation: brachytherapyRadiation: low-LET electron therapyDrug: endocrine-modulating drug therapyRadiation: low-LET photon therapyRadiation: radiation therapy
- First Posted Date
- 2009-06-29
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1558
- Registration Number
- NCT00929591
S9925: Collecting and Storing Samples From Patients With Lung Cancer
Completed
- Conditions
- Lung Cancer
- First Posted Date
- 2009-06-12
- Last Posted Date
- 2015-02-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 2264
- Registration Number
- NCT00920010
- Locations
- 🇺🇸
Piedmont Hospital, Atlanta, Georgia, United States
🇺🇸Northside Hospital Cancer Center, Atlanta, Georgia, United States
🇺🇸Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
© Copyright 2025. All Rights Reserved by MedPath